Pending EC decisions on maximum residue limits

The European Medicines Agency (EMA) publishes summaries of opinion on maximum residue limits for active substances contained in veterinary medicines, which have been assessed by the EMA's Committee for Medicinal Products for Veterinary Use (CVMP) and are currently pending the adoption of a legally binding Regulation by the European Commission.

In the European Union, a maximum residue limit (MRL) is the maximum acceptable concentration of a substance that may be found in a food product obtained from an animal that has received a veterinary medicine.

The CVMP carries out a safety assessment for each substance and issues a scientific opinion. Immediately after the CVMP opinion is adopted, the EMA publishes a summary of opinion.

For a full list of summaries of opinions on MRLs, see:

• MRLs: summaries of opinions.

Based on the CVMP opinion, the European Commission adopts a legally binding Regulation establishing the MRL for each substance. Once the Commission Regulation has been issued, the Agency publishes detailed information on the assessment in the form of a European public maximum-residue-limit assessment report (EPMAR). These can be found in Maximum residue limit assessment reports.